![]() |
Registration: 5:15 AM - 5:30 PM Registration for this program is now closed. |
Program Overview:
Iron deficiency (ID) is common in patients with heart failure (HF), and ID is increasingly recognized as an important comorbidity in HF, even in the absence of anemia. ID is independently associated with worse functional capacity, lower quality of life (QOL), and an increased risk for hospitalization and mortality. Although HF guidelines recommend regular screening for ID with iron studies (serum iron, ferritin, transferrin saturation (TSAT), these studies are often not conducted, and therefore ID is underdiagnosed. Consequently, HF patients with ID are undertreated. Oral iron is ineffective in HF patients and is not recommended in HF guidelines. Conversely, intravenous (IV) repletion of iron has been shown to improve exercise capacity and QOL and is recommended in HF guidelines. Furthermore, IV iron supplementation with the ferric carboxymaltose (FCM) formulation reduces HF and cardiovascular (CV) hospitalizations as demonstrated in a meta-analysis of over 4,000 patients. Numerous potential barriers to diagnosis of ID and treatment with IV iron can be present, and therefore a multidisciplinary team effort involving physicians, nurses, and pharmacists can ensure that challenges are satisfactorily addressed. Therefore, in this educational initiative, to take place at the 2024 Heart Failure Society of America annual meeting, attendees will be provided with information on the detrimental impact of ID in patients with HF, tests for screening for ID, a definition to determine a diagnosis of ID, and evidence demonstrating the benefits achieved with IV iron therapy. A case study will focus on overcoming challenges in HF patient care with multidisciplinary teamwork, following best practices outlined in an expert-generated algorithm published in a scientific statement from the Heart Failure Society of America (HFSA). |
|
Educational Objectives: Accreditation & Credit Designation: Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Voxmedia LLC designates this live activity for a maximum of 1.0 AMA PRA Category Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1.0 Credits Educational Grant: Voxmedia International gratefully acknowledges the independent educational grant provided by American Regent. Disclosure Statement: Voxmedia strives to ensure fair-balance, independence, objectivity, and scientific rigor in all directly or jointly sponsored educational activities. All prospective faculty are required to disclose to Voxmedia all financial relationships for the preceding 24 months (1) with any commercial interest producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients AND (2) with any commercial supporters prior to participating in the planning of an activity or developing content. Only after Voxmedia mitigates all financial relationships may faculty receive approval to participate, and are expected to contribute evidence-based material. Faculty are required to indicate areas of their presentation that are based on professional opinion vs. guidelines, meta-analysis. All information submitted will be peer-reviewed. The intent of this disclosure is not to prevent faculty from participating, but rather to provide learners with information on which they can make their own judgment of commercial bias. Voxmedia will disclose to learners that all relevant financial relationships have been mitigated in either written materials, visually and/or verbally. It remains for the audience to determine whether the speaker s interests or relationships may influence the presentation. Speakers must make a meaningful disclosure to the audience of their discussions of any unlabeled or investigational use(s) of drugs or devices. |